Skip to content

The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic

Investigation of the Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic on the Depression, Attachment and Anxiety Levels of Women: A Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04847362
Enrollment
74
Registered
2021-04-19
Start date
2021-04-11
Completion date
2022-01-30
Last updated
2021-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety State, Postpartum Depression

Keywords

postpartum depression, mother-baby attachment, anxiety

Brief summary

In the planned study, it was aimed to examine the effect of tele-education offered in the postpartum period in the covid 19 pandemic on the levels of depression, attachment and anxiety of women.

Detailed description

In the planned study, it was aimed to examine the effect of tele-education offered in the postpartum period in the covid 19 pandemic on the levels of depression, attachment and anxiety of women.

Interventions

BEHAVIORALExperimental

education group

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Intervention model description

A randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* literate * Giving birth at term (between 38-42 weeks of gestation) * Being on the 7th Postpartum Day, * Participation in the study is voluntary, * Absence of any psychiatric illness, * Women who have characteristics such as not using any psychiatric medication. * Baby with normal birth weight and APGAR score of 8 and above * Those who have not developed postpartum complications * Speaks and understands Turkish

Exclusion criteria

women who do not meet the sample selection criteria \-

Design outcomes

Primary

MeasureTime frameDescription
postpartum depressionpostpartum 6 weeksThe Edinburgh Postnatal Depression Scale (EPDS) was used to detect depressive symptoms during the postpartum period \[30\]. EPDS is a 10-item questionnaire assessing the interviewee's depressive feelings from the seven days before the interview. The response of the questions is scored from 0-3, with higher scores indicating higher levels of depressive symptoms. The total EPDS score of a respondentcan range from 0 to 30.
postpartum mother-baby attachmentpostpartum 6 weeks aPostpartum Attachment Scale: Early diagnosis of problems in mother-infant relationship Developed to provide and maternal filling4. The scale is a six-digit It has a Likert scale. Scale always, Postpartum attachment scales in mothers 247 Very often, often, sometimes, rarely, no It has been defined as time. Items 0-5 It is rated as. Scale 17 is reverse It consists of 25 graded items. Scale attachment disorder (12 items), Rejection and irritability (seven items), care tension about (four items), abuse four sub-categories with risk (two substances) It consists of units. Pathology in mother-infant relationship cut point specified for four subscales 4'18 The cut-off point of four subscales attachment disorder (subscale 1), respectively\> 12, rejection and irritability (subscale 2)\> 17, anxiety in infant care (subscale 3)\> 10, the risk of abuse (subscale 4) is\> 3.
anxiety statepostpartum 6 weeksState Anxiety Scale (STAI-I) in 1970 Turkish form developed by Spielberger Oner N et al. Its validity and reliability study has been carried out by adapting it. Anxiety level In STAI-I, (1) not at all, (2) a little, (3) a lot and (4) completely While it is scored as, the options in STAI-II are (1) almost never, (2) sometimes, (3) a lot of time, and (4) it is almost always. 2 kinds of scales Scores obtained from both scales theoretically it ranges from 20 to 80. High score indicates high anxiety level

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026